Company News
Aurobindo Pharma Subsidiary Receives US FDA OAI Classification
Aurobindo Pharma discloses US FDA OAI classification for Lannett Company LLC subsidiary after August 2026 inspection.
US FDA issued four observations following inspection at Seymour, IN facility from